NECTAR LIFESCIENCES LTD. - 532649 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- AnubhaDesignation :- Company Secretary and Compliance Officer NECTAR LIFESCIENCES LTD. - 532649 - Closure of Trading Window
Pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the trading window of the Company is closed from January 1, 2022 till 48 hours after the declaration of Financial Results for the period ended on December 31, 2021. NECTAR LIFESCIENCES LTD. - 532649 - Disclosure Of Related Party Transactions For The Half Year Ended On September 30, 2021.
Pursuant to Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed the disclosure on Related Party Transactions of Nectar Lifesciences Limited on a consolidated basis for half year ended on September 30, 2021. NECTAR LIFESCIENCES LTD. - 532649 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are furnishing herewith newspaper copy of Publication of Financial Results of the Company for the quarter ended on September 30, 2021, which have been published in the following newspapers: 1. Business Standard (English-all editions) dated 15.11.2021. 2. Desh Sewak (Punjabi) dated 15.11.2021 Nectar Lifesciences Ltd - 532649 - Outcome Of Board Meeting And Sale Of Non-Core Assets/ Core Assets Which Are Unproductive/ Less Productive
Nectar Lifesciences Limited has informed the Exchange regarding ''Outcome of Board Meeting and Sale of Non-Core Assets/ Core Assets which are unproductive/ less productive''. NECTAR LIFESCIENCES LTD. - 532649 - Unaudited Financial Results For The Period Ended On September 30, 2021.
The Board of Directors of the Company at their meeting held today duly approved and took on record the limited reviewed Unaudited Standalone and Consolidated Financial results for the quarter and half year ended on September 30, 2021, which are enclosed herewith along with the Limited Review Reports of the Auditors thereon. Nectar Lifesciences Ltd - 532649 - Board Meeting Intimation for Financial Results For Period Ended On September 30, 2021.
NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter and half year ended on September 30, 2021. Nectar Lifesciences Ltd - 532649 - Shareholding for the Period Ended September 30, 2021
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here NECTAR LIFESCIENCES LTD. - 532649 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0330 Name of the Signatory :- AnubhaDesignation :- Company Secretary and Compliance Officer NECTAR LIFESCIENCES LTD. - 532649 - Closure of Trading Window
Pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the trading window of the Company is closed from October 1, 2021 till 48 hours after the declaration of Financial Results for the period ended on September 30, 2021.